Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week

Latest news

Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
  • FDA
  • Movers
  • News
  • Trading Ideas

Teva And MedinCell Receive Complete Response Letter For TV-46000/mdc-IRM; Teva Shares Move Lower

By Benzinga Newsdesk
Today, 10:45 PM
Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), and MedinCell (Euronext: MEDCL) announced that the U.S. Food and Drug Administration ("FDA") has issued a

TEVA

Read More
21 minute read
  • Analyst Ratings
  • Downgrades
  • Initiation
  • Intraday Update
  • Upgrades

Benzinga’s Top Ratings Upgrades, Downgrades For April 5, 2022

By Benzinga Insights
Today, 10:45 PM
Upgrades

AAWW

Read More
1 minute read
  • Analyst Ratings
  • News
  • Price Target
  • Upgrades

Barclays Upgrades Teva Pharmaceutical Indus to Overweight, Raises Price Target to $13

By Benzinga Newsdesk
Today, 10:45 PM
Barclays analyst Balaji Prasad upgrades Teva Pharmaceutical Indus (NYSE:TEVA) from Equal-Weight to Overweight and raises the price target from $11 to $13.

TEVA

Read More
1 minute read
  • Biotech
  • General
  • Health Care
  • Legal
  • Movers
  • News
  • Penny Stocks
  • Small Cap
  • Trading Ideas

West Virginia Says J&J, Teva, AbbVie Caused ‘Tsunami’ Of Opioid Addiction: Reuters

By Vandana Singh
Today, 10:45 PM
West Virginia's attorney general urged a judge to hold Johnson & Johnson (NYSE: JNJ), Teva Pharmaceuticals Industries Ltd (NYSE: TEVA), and AbbVie Inc's (NYSE:

ABBV

Read More
1 minute read
  • Contracts
  • News

Teva Pharmaceuticals Wins $109.085M Department Of Veterans Affairs Contract For ‘Albuterol HFA w Dose Counter’

By Benzinga Newsdesk
Today, 10:45 PM
https://sam.gov/opp/4862b70874f24f719f32cbcb873c4359/view

TEVA

Read More
1 minute read
  • Biotech
  • General
  • Health Care
  • Legal
  • News

Rhode Island Announces $107M Opioid Settlements With Teva, Allergan: Reuters

By Vandana Singh
Today, 10:45 PM
Rhode Island's attorney general announced settlements worth $107 million against Teva Pharmaceutical Industries Ltd (NYSE: TEVA) and AbbVie Inc's (NYSE: ABBV) Allergan unit to resolve claims over

ABBV

Read More
1 minute read
  • Biotech
  • Contracts
  • General
  • Government
  • Health Care
  • News

35 Generic Drugmakers Sign To Manufacture Low-Cost Version Of Pfizer’s COVID Pill

By Vandana Singh
Today, 10:45 PM
Thirty-five generic drugmakers will produce low-cost versions of Pfizer Inc’s (NYSE:PFE) COVID-19 pill, Paxlovid, to expand supplies of the highly effective drug…

PFE

Read More
1 minute read
  • Biotech
  • General
  • Health Care
  • Legal
  • News

Rhode Island’s Opioid Trial Against Teva Begins Today: Reuters

By Vandana Singh
Today, 10:45 PM
The first trial in Rhode Island state court against Teva Pharmaceutical Industries Ltd’s (NYSE:TEVA) alleged responsibility for the opioid crisis begins…

TEVA

Read More
32 minute read
  • Intraday Update
  • Markets
  • Movers
  • News
  • Options
  • Trading Ideas

Stocks That Hit 52-Week Lows On Monday

By Benzinga Insights
Today, 10:45 PM
    On Monday, 524 stocks hit new 52-week lows.

AAL

Read More
22 minute read
  • Intraday Update
  • Markets
  • Movers
  • News
  • Options
  • Trading Ideas

Stocks That Hit 52-Week Lows On Friday

By Benzinga Insights
Today, 10:45 PM
    On Friday, 368 stocks hit new 52-week lows.

AAL

Posts navigation

Previous 1 … 7 8 9 … 14 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service